Pharmacology: Difference between revisions

No edit summary
No edit summary
Line 52: Line 52:


Richard Sullivan, Isabel Behncke and Arnie Purushotham  
Richard Sullivan, Isabel Behncke and Arnie Purushotham  
Ibogaine - Rite of Passage (Documentary)
<youtube>dtJ_smUrDaA</youtube>


== Juridico-pharmacology<br> ==
== Juridico-pharmacology<br> ==
Line 69: Line 73:
Mike Trace  
Mike Trace  


[http://www.emcdda.europa.eu/attachements.cfm/att_137215_EN_PolicyProfile_Portugal_WEB_Final.pdf European Monitoring Centre for Drugs and Drug Addiction - Portugal's Drugs Policy]
[http://www.emcdda.europa.eu/attachements.cfm/att_137215_EN_PolicyProfile_Portugal_WEB_Final.pdf European Monitoring Centre for Drugs and Drug Addiction - Portugal's Drugs Policy]  


[http://www.globaldrugpolicy.org/5/1/1.php The UK’s Treatment War on Drugs: A Lesson in Unintended Consequences and Perverse Outcomes]<br>Kathy Gyngell<br>
[http://www.globaldrugpolicy.org/5/1/1.php The UK’s Treatment War on Drugs: A Lesson in Unintended Consequences and Perverse Outcomes]<br>Kathy Gyngell<br>

Revision as of 11:35, 12 July 2011

Introduction (coming soon)

Drugs 'R Us

Dave Boothroyd


Socio-pharmacology

Epidemiology Meets Cultural Studies: Studying and Understanding Youth Cultures, Clubs and Drugs
Geoffrey Hunt, Molly Moloney, and Kristin Evans

Misuse of "study drugs:" prevalence, consequences, and implications for policy
Steve Sussman, Mary A Pentz, Donna Spruijt-Metz and Toby Miller

Coming to terms with the nonmedical use of prescription medications
Carol J Boyd and Sean E McCabe

A Better Approach to Drugs and Alcohol

Stanton Peele

 &nbsp


Psycho-pharmacology

Psychopharmacology and the Goverment of the Self

David Healy

Do Antidepressants Cure or Create Abnormal Brain States?

Joanna Moncrieff and David Cohen


Neuro-pharmacology

The Dark Side of Ecstasy: Neuropsychiatric  Symptoms After Exposure to 3,4-Methylenedioxymetamphetamine
Sunniva Nyberg Karlsen, Olav Spigset, LARS Slørdal
Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs
John H. Halpern, Andrea R. Sherwood, James I. Hudson, Staci Gruber, David Kozin, Harrison G. Pope Jr

Effectiveness of antidepressants: an evidence myth constructed
from a thousand randomized trials
?
John PA Ioannidis

Should We Treat Depression with drugs or
psychological interventions? A Reply to Ioannidis

John M Davis, William J Giakas, Jie Qu, Pavan Prasad and Stefan Leucht


Ethno-pharmacology

Naming a Phantom - the Quest to Find the Identity of the Ulluchu, an Unidentified Cerimonial Plant of the Moche Culture in Northern Peru
Rainer W Bussmann and Douglas Sharon
Absinthism: A Fictitious 19th. Centrury Syndrome with Present Impact
Stephan A Padosch, Dirk W Lachenmeier and Lars U Kröner
The “Vine of the Soul” vs. The Controlled Substances Act: Implications of the Hoasca Case
Ronald K. Bullis


Anthropo-pharmacology

The evolutionary origins and significance of drug addiction
Tammy Saah

Why Do We Love Medicines So Much?

Richard Sullivan, Isabel Behncke and Arnie Purushotham

Ibogaine - Rite of Passage (Documentary)

Juridico-pharmacology

Our Right to Drugs

An interview with Thomas Szasz

 


Global Commission on Drugs Report (2011)

Drug Policy – Lessons Learnt, and Options for the Future

Mike Trace

European Monitoring Centre for Drugs and Drug Addiction - Portugal's Drugs Policy

The UK’s Treatment War on Drugs: A Lesson in Unintended Consequences and Perverse Outcomes
Kathy Gyngell

Cultural psycho-pharmacology

Timothy Leary, Cooper Union Addess, 1964

 


Narco-cultural theory

Deposition: Drugs in Theory

Dave Boothroyd

Machinic Assemblages: Deleuze, Guattari and an Ethico-Aesthetics of Drug Use
Peta Malins


Placebo

Deception in Research on the Placebo Effect

Franklin G. Miller, David Wendler, Leora C. Swartzman

Effects of perceived cocaine availability on subjective and objective responses to the drug
Rinah T Yamamoto, Katherine H Karlsgodt, David Rott, Scott E Lukas and Igor Elman


Understanding the Placebo Effect

Roundtable discussion with Robert Ader, Rob DeRubeis, John Kelley, Richard Kradin, and Rosamond Rhodes

 


Heroes of Drugs Research

PHIKAL (Part 2)

Alexander Shulgin

Alexander Flemming